Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma.
Jiyoung RheeJaemin JoSang-Hoon HanJung-Mi KwonPublished in: Annals of dermatology (2019)
No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies: colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was treated with capecitabine and oxaliplatin after surgery for colon cancer. Surprisingly, he achieved a complete response for basal cell carcinoma. This is the first report of this chemotherapy regimen in basal cell carcinoma. This finding suggests that combination capecitabine and oxaliplatin can be a treatment option for patients unable to receive local therapy.
Keyphrases
- basal cell carcinoma
- locally advanced
- phase ii study
- end stage renal disease
- newly diagnosed
- multiple myeloma
- rectal cancer
- metastatic breast cancer
- squamous cell carcinoma
- ejection fraction
- chronic kidney disease
- metastatic colorectal cancer
- radiation therapy
- phase iii
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- clinical trial
- patient reported outcomes
- replacement therapy